CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$4.43 USD
-0.07 (-1.56%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.67 +0.24 (5.42%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: AMC |
3/2024 | $-0.03 | -340.00% |
Earnings Summary
For their last quarter, CytomX Therapeutics (CTMX) reported earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.02 per share. This reflects a negative earnings surprise of 50.00%. Look out for CTMX's next earnings release on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.03 per share, reflecting a year-over-year increase of 40%.
Earnings History
Price & Consensus
Zacks News for CTMX
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
CTMX: What are Zacks experts saying now?
Zacks Private Portfolio Services